Cargando…
Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659999/ https://www.ncbi.nlm.nih.gov/pubmed/37738174 http://dx.doi.org/10.1182/bloodadvances.2023010742 |